title: Efficacy of local sclerosing agents on hemostasis of hepatic bleeding.
abstract: OBJECTIVE
  Hepatic bleeding following abdominal trauma is a serious problem. The implementation of various materials and techniques have been attempted to prevent bleeding but a standard method is indefinite.
  
  
  METHODS
  Hepatic resection model was performed on rats. The efficacy of hemostasis with Polidocanol and Tetradecyl Sulfate has been evaluated through the comparison of perioperative bleeding amount and preoperative and postoperative hematocrit levels in the 24th hour. Also, histopathologic changes on parenchyma have been compared at a microscopic level.
  
  
  RESULTS
  Preoperative and postoperative hematocrit differences were 5.50 +/- 0.59 in Polidocanol group and 10 +/- 1.30 in Tetradecyl Sulfate group (MW: 2, p < 0.001). Perioperative bleeding amounts were: 1.50 +/- 0.20 mL in the Polidocanol group, 3.50 +/- 0.15 mL in the Tetradecyl Sulfate group and 7.50 +/- 0.41 mL in the Control Group. Upon comparison of perioperative bleeding amounts: the Control Group values were very high in comparison to the Polidocanol group (p < 0.001) and the Tetradecyl Sulfate group values were higher than those of the Polidocanol group (p < 0.05).
  
  
  CONCLUSIONS
  Local sclerosing agents, especially Polidocanol, appear to be an effective alternative method in hemostasis of hepatic bleeding.
authors.affiliation: General Surgery Department, S.B. Istanbul Education and Research Hospital Istanbul, Turkey.
authors.forename: Erhan
authors.initials: E
authors.lastname: Aysan
authors.forename: Fatih
authors.initials: F
authors.lastname: Basak
authors.forename: Erdem
authors.initials: E
authors.lastname: Kinaci
authors.forename: Hamdi
authors.initials: H
authors.lastname: Tutuncu
mesh_terms: D000818:Animals; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy*; D006487:Hemostasis / Q000187:drug effects*; D008107:Liver Diseases / Q000188:drug therapy*; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D012597:Sclerosing Solutions / Q000494:pharmacology / Q000627:therapeutic use*; D012981:Sodium Tetradecyl Sulfate / Q000627:therapeutic use*
chemical_list: D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols; D012981:Sodium Tetradecyl Sulfate